Effect of the PTPN22 and INS risk genotypes on the progression to clinical type 1 diabetes after the initiation of β-cell autoimmunity

Diabetes

Volumn 61, Issue 4, 2012, Pages 963-966

  Lempainen, Johanna ^a   Hermann, Robert ^a   Veijola, Riitta ^b   Simell, Olli ^a   Knip, Mikael ^c,d,e   Ilonen, Jorma ^a,f  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e FOLKHÄLSAN RESEARCH CENTER   (Finland)

^f UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA ANTIGEN CLASS 2; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR3 ANTIGEN; INSULIN; INSULIN ANTIBODY; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PANCREAS ISLET CELL ANTIBODY;

ARTICLE; AUTOIMMUNITY; BIOCHEMICAL COMPOSITION; CHILD; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMORAL IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SCHOOL CHILD;

AUTOIMMUNITY; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; GENOTYPE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MALE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; RISK FACTORS;

EID: 84859545808     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-0386     Document Type: Article

References (24)

1. Eisenbarth GS. Update in type 1 diabetes. J Clin Endocrinol Metab 2007;92: 2403-2407
2. Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J Med 2009;360:1646-1654
3. Knip M. Natural course of preclinical type 1 diabetes. Horm Res 2002;57 (Suppl. 1):6-11 (Pubitemid 34458074)
4. Tait BD, Colman PG, Morahan G, et al. HLA genes associated with autoimmunity and progression to disease in type 1 diabetes. Tissue Antigens 2003;61:146-153 (Pubitemid 36549600)
5. Lipponen K, Gombos Z, Kiviniemi M, et al. Effect of HLA class I and class II alleles on progression from autoantibody positivity to overt type 1 diabetes in children with risk-associated class II genotypes. Diabetes 2010;59:3253-3256
6. Butty V, Campbell C, Mathis D, Benoist C; DPT-1 Study Group. Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1). Diabetes 2008;57:2348-2359
7. Kupila A, Muona P, Simell T, et al.; Juvenile Diabetes Research Foundation Centre for the Prevention of Type I Diabetes in Finland. Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort. Diabetologia 2001;44:290-297
8. Hermann R, Lipponen K, Kiviniemi M, et al. Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes. Diabetologia 2006;49:1198-1208
9. Laine AP, Holmberg H, Nilsson A, et al.; Finnish Paediatric Diabetes Registry. Two insulin gene single nucleotide polymorphisms associated with type 1 diabetes risk in the Finnish and Swedish populations. Dis Markers 2007;23:139-145 (Pubitemid 46868403)
10. Steck AK, Zhang W, Bugawan TL, et al. Do non-HLA genes influence development of persistent islet autoimmunity and type 1 diabetes in children with high-risk HLA-DR,DQ genotypes? Diabetes 2009;58:1028-1033
11. Gregersen PK, Lee HS, Batliwalla F, Begovich AB. PTPN22: setting thresholds for autoimmunity. Semin Immunol 2006;18:214-223 (Pubitemid 43903284)
12. Pugliese A. Central and peripheral autoantigen presentation in immune tolerance. Immunology 2004;111:138-146 (Pubitemid 38177942)
13. Pugliese A, Zeller M, Fernandez A Jr, et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 1997;15:293-297 (Pubitemid 27098726)
14. Vafiadis P, Bennett ST, Todd JA, et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 1997;15: 289-292 (Pubitemid 27098725)
15. Graham J, Hagopian WA, Kockum I, et al.; Diabetes Incidence in Sweden Study Group; Swedish Childhood Diabetes Study Group. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 2002;51:1346-1355
16. Hermann R, Laine AP, Veijola R, et al. The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral beta cell autoimmunity. Diabetologia 2005;48:1766-1775 (Pubitemid 41317830)
17. Ziegler AG, Hummel M, Schenker M, Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 1999;48:460-468 (Pubitemid 29106857)
18. Kukko M, Kimpimäki T, Korhonen S, et al. Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 2005;90:2712-2717 (Pubitemid 40686314)
19. Vang T, Congia M, Macis MD, et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005;37:1317-1319 (Pubitemid 41722185)
20. Rieck M, Arechiga A, Onengut-Gumuscu S, Greenbaum C, Concannon P, Buckner JH. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J Immunol 2007;179:4704-4710
21. Aarnisalo J, Treszl A, Svec P, et al. Reduced CD4+T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variant. J Autoimmun 2008;31:13-21
22. Burn GL, Svensson L, Sanchez-Blanco C, Saini M, Cope AP. Why is PTPN22 a good candidate susceptibility gene for autoimmune disease? FEBS Lett 2011;585:3689-3698
23. Petrone A, Spoletini M, Zampetti S, et al.; Immunotherapy Diabetes (IMDIAB) Group. The PTPN22 1858T gene variant in type 1 diabetes is associated with reduced residual beta-cell function and worse metabolic control. Diabetes Care 2008;31:1214-1218
24. Nielsen LB, Pörksen S, Andersen ML, et al.; Hvidoere Study Group on Childhood Diabetes. The PTPN22 C1858T gene variant is associated with proinsulin in new-onset type 1 diabetes. BMC Med Genet 2011;12:41